RE: [CANSLIM] ACDO, SRA

From: "Tim Fisher" <Tim@orerockon.com>
Subject: RE: [CANSLIM] ACDO, SRA
Date: 8 Mar 2002 11:55:29 -0800

Next Article (by Author): Re: [CANSLIM] ACDO, SRA "Tom Worley"
Previous Article (by Author): RE: [CANSLIM] ACDO, SRA "Tim Fisher"
Top of Thread: RE: [CANSLIM] ACDO, SRA "Rich Mau"
Next in Thread: Re: [CANSLIM] ACDO, SRA "Tom Worley"
Articles sorted by: [Date] [Author] [Subject]

Yeech. Think I'll pass...

Picked up FRED (round 2) and AAII when it looked like they might BO this 
AM. So far so good...vol was already there on AAII, and FRED was running 
ahead of average, but looks to have dropped off. It actually broke out 
yesterday but didn't pass the pivot until the gap up at the open today.

At 12:11 PM 3/8/2002 -0700, you wrote:
>According to Quotes Plus, earnings have fallen off from a couple bucks a 
>share per
>quarter to the 10 to 16 cents per share range over the last 4 
>quarters.  Their EPS
>number is 6, RS is 35
>
>On 8 Mar 2002 at 10:53, Tim Fisher wrote:
>
> > Actually, I meant EPS/RS/GRS etc....
> >
> > At 10:50 AM 3/8/2002 -0800, you wrote:
> > >[From Yahoo]
> > >Serono S.A., headquartered in Geneva, Switzerland, is a global
> > >biotechnology company with six recombinant products on the market:
> > >Gonal-F, Luveris, Ovidrel/Ovitrelle, Rebif, Serostim and Saizen (Rebif 
> and
> > >Luveris are not approved in the United States). In addition to
> > >reproductive health, Serono has strong market positions in neurology,
> > >metabolism and growth. The Company's research programs are focused on
> > >growing these businesses and on establishing new therapeutic areas.
> > >Currently, there are 15 new molecules in development. The Company 
> operates
> > >in 45 countries, and its products are sold in over 100 countries.
> > >More from Market Guide:
> > >
> > >
> > > > -----Original Message-----
> > > > From: owner-canslim@lists.xmission.com
> > > >
> > > 
> [<mailto:owner-canslim@lists.xmission.com>mailto:owner-canslim@lists.xmission.com]On 
>
> > > Behalf Of Tim Fisher
> > > > Sent: Friday, March 08, 2002 9:46 AM
> > > > To: canslim@mail.xmission.com
> > > > Subject: [CANSLIM] ACDO, SRA
> > > >
> > > >
> > > > Noticed the reason for ACDO's tumble this AM was SRA got approval for a
> > > > drug that has a different distributor. Anyone know anything about 
> SRA? It
> > > > doesn't show up in my scans...
> > > >
> > > >
> > > > Tim Fisher
> >

Tim Fisher
Ore-ROCK-On Rockhounding Web Site
Owner, Fisher Fisheries, Ltd.
mailto:tim@OreRockOn.com
WWW http://OreRockOn.com


- -
- -To subscribe/unsubscribe, email "majordomo@xmission.com"
- -In the email body, write "subscribe canslim" or
- -"unsubscribe canslim".  Do not use quotes in your email.

Go to Jeff Salisbury LWGate Home Page.